Skip To Main Content
Eugene J. Barrett on Muck Rack

Eugene J. Barrett

As seen in: JAMA: Journal of the American Medical Association, Newswise
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eugene J.

Contact Eugene J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Metformin Improves Insulin Sensitivity in Muscles’ Microvascular System

|
By Lee Hartline, Zhenqi Jessie Liu, Eugene J. Barrett
| Newswise
Article title: Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome Authors: Linda A. Jahn, Lee Hartline, Zhenqi Liu, Eugene J. Barrett From the authors: “Here, we provide the first evidence for metformin improving muscle microvascular insulin sensitivity in insulin-resistant humans.
Open in Who Shared Issue with article?

Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome

|
By Linda A. Jahn, Lee Hartline, Zhenqi Jessie Liu, Eugene J. Barrett
| American Physiological Society
Metabolic syndrome closely associates with metabolic insulin resistance and increases the cardiovascular disease (CVD) event risk (1). Clinical interventions to lessen the risk of adverse outcomes from metabolic syndrome consist of lifestyle modification and treating syndrome components (i.e., hypertension, obesity, dysglycemia, hypertriglyceridemia, and low HDL cholesterol) (2). Other than dysglycemia, metformin does not target specific metabolic syndrome components.
Open in Who Shared Issue with article?

Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

|
By Lawrence H. Young, Deborah Chyun, Janice A. Davey, Eugene J. Barrett
| JAMA: Journal of the American Medical Association Verified
Abstract Context Coronary artery disease (CAD) is the major cause of mortality and morbidity in patients with type 2 diabetes. But the utility of screening patients with type 2 diabetes for asymptomatic CAD is controversial. Objective To assess whether routine screening for CAD identifies patients with type 2 diabetes as being at high cardiac risk and whether it affects their cardiac outcomes.
Open in Who Shared Issue with article?
See all 3 articles